COVID-KOSHA
Home
Help
(current)
Comment
!
Note: Language translations may be imperfect
A model anti-pandemic portal for scientists & public
;
High priority articles (R1, Most articles most likely to be relevant):
Second priority articles (R2, Moderate portion of articles likely to be relevant):
Other articles (R3, Lesser portion of articles likely to be relevant):
Auto Summaries -
Epidemiology
Last updated: 2025 Jul 18
Total hit(s): 21657
S.No.
PMID
Ascending order
Descending order
Title
Ascending order
Descending order
Auto Summary
Ascending order
Descending order
Journal Name
Ascending order
Descending order
Publish Date
Ascending order
Descending order
Impact Factor
Ascending order
Descending order
Citations
Ascending order
Descending order
1
40619244
Erratum: "Coffee and green tea consumption with the risk of COVID-19 among the vaccine recipients in Japan: a prospective study" [J Epidemiol 34(9) (2024) 444-452].
N/A
J Epidemiol
2025 Jul 5
5.8
1
2
40674101
COVID-19 Pandemic and Posttreatment Breast Cancer Surveillance and Outcomes.
N/A
JAMA Oncol
2025 Jul 17
13.86
1
3
40654050
Excess respiratory, circulatory, neoplasm and other mortality rates during the Covid-19 pandemic in the EU and their implications.
N/A
Epidemiol Infect
2025 Jul 14
2.01
1
4
40646192
Saliva's role in COVID-19 transmission and innovation.
N/A
Br Dent J
2025 Jul
1.07
1
5
40488589
Cutaneous Squamous Cell Carcinoma in the Post-COVID-19 Era: Dramatic Increase of New Cases in 2023 in Two German Skin Tumour Centers.
N/A
Acta Derm Venereol
2025 Jun 9
3.01
1
6
40459240
Differentiating SARS-CoV-2 antibody responses between infection and vaccination: challenges for epidemiological research.
N/A
J Infect Dis
2025 Jun 3
4.73
1
7
40579769
Impact of the COVID-19 pandemic on TB epidemiology.
N/A
Int J Tuberc Lung Dis
2025 Jun 27
4.1
1
8
40560295
Obstructive sleep apnea is a risk factor for incident COVID-19 infection.
N/A
Sleep Breath
2025 Jun 25
2.42
1
9
40457307
Correction: Assessing the impact of an evidence- and consensus-based guideline for controlling SARS-CoV-2 transmission in German schools on decision-making processes: a multi-component qualitative analysis.
N/A
Health Res Policy Syst
2025 Jun 2
5.5
1
10
40525456
Comparative Analysis of Instantaneous Reproduction Number Using ILI (Influenza-Like Illness) Surveillance Data in the Republic of Korea: Before, During, and After the COVID-19 Pandemic.
N/A
Asia Pac J Public Health
2025 Jun 17
1.85
1
11
40104250
A Canadian multi-province study of COVID-19 vaccine coverage along area-level social determinants in 2021.
N/A
Public Health Pract (Oxf)
2025 Jun
3.4
1
12
40343624
Correction: Routine vaccination coverage at ages 2 and 7, before, during, and after the COVID-19 pandemic: Results from the STARVAX surveillance system.
N/A
Can J Public Health
2025 May 9
2.3
1
13
40451512
Cardiovascular Events in hospitalized COVID-19 patients: incidence, in-hospital mortality and fatality rates. Results from the HERICCO study by the Working Group of Echocardiology of the Hellenic Cardiology Society.
N/A
Hellenic J Cardiol
2025 May 30
6.8
1
14
40441063
Corrigendum to "Underlying health biases in previously-infected SARS-CoV-2 vaccination recipients: A cohort study" [J Infect 90 (2025) 106497].
N/A
J Infect
2025 May 28
5.1
1
15
40405815
Data for action - description of the automated COVID-19 surveillance system in Denmark and lessons learnt, January 2020 to June 2024 - CORRIGENDUM.
N/A
Epidemiol Infect
2025 May 23
2.01
1
16
40490390
Preventing COVID-19 in Correctional Facilities: The Impact of Rapid Antigen Tests on Early Detection and Infection Control.
N/A
Infect Chemother
2025 May 22
1.94
1
17
40376806
Isolating the burden of transmission-based precautions for COVID-19: walk-in clinic-based healthcare personnel perspectives.
N/A
Infect Control Hosp Epidemiol
2025 May 16
2.66
1
18
40383396
Novel coronaviruses identified in livestock: The urgent need to enhance coronavirus surveillance to mitigate zoonotic risks.
N/A
J Infect
2025 May 16
5.1
1
19
40173425
Erratum: Comparison of the Test-negative Design and Cohort Design With Explicit Target Trial Emulation for Evaluating COVID-19 Vaccine Effectiveness.
N/A
Epidemiology
2025 May 1
4.65
1
20
40203252
Sexually Transmitted Infection Cases During COVID-19: Implications for Public Health.
N/A
Am J Public Health
2025 May
4.21
1
21
40183376
A plain language summary of the available safety data for the BNT162b2 COVID-19 vaccine: development, approval, and surveillance of use.
N/A
Expert Rev Vaccines
2025 Apr 4
4.37
1
22
40287005
Comment on: "COVID-19 Vaccination and Ocular Adverse Events: A Self-Controlled Case Series Study From the Entire South Korean Population".
N/A
Am J Ophthalmol
2025 Apr 24
7.1
1
23
40264377
Severe COVID-19 and inactivated vaccine in diabetic patients with SARS-CoV-2 infection.
N/A
Chin Med J (Engl)
2025 Apr 23
1.053
1
24
40122247
Rapid spread of Candida auris in China after COVID-19.
N/A
J Infect
2025 Apr
5.1
1
25
40159907
SARS-CoV-2 infection and vaccination status in six ethnic groups in Amsterdam, The Netherlands, May to November 2022 - CORRIGENDUM.
N/A
Epidemiol Infect
2025 Mar 31
2.01
1